Free Trial

OncoSec Medical (ONCSQ) Competitors

ONCSQ vs. EFTR, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, and BTMDW

Should you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include eFFECTOR Therapeutics (EFTR), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

OncoSec Medical vs. Its Competitors

eFFECTOR Therapeutics (NASDAQ:EFTR) and OncoSec Medical (NASDAQ:ONCSQ) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

eFFECTOR Therapeutics has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, OncoSec Medical has a beta of -19.7, suggesting that its share price is 2,070% less volatile than the S&P 500.

Company Net Margins Return on Equity Return on Assets
eFFECTOR TherapeuticsN/A N/A N/A
OncoSec Medical N/A N/A N/A

In the previous week, eFFECTOR Therapeutics' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
eFFECTOR Therapeutics Neutral
OncoSec Medical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
eFFECTOR TherapeuticsN/AN/A-$35.81M-$13.080.00
OncoSec MedicalN/AN/A-$34.18MN/AN/A

57.7% of eFFECTOR Therapeutics shares are owned by institutional investors. 4.7% of eFFECTOR Therapeutics shares are owned by company insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

eFFECTOR Therapeutics beats OncoSec Medical on 3 of the 4 factors compared between the two stocks.

Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

MetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$817.60M$5.55B$9.40B
Dividend YieldN/A4.84%3.75%4.03%
P/E RatioN/A1.4128.0119.82
Price / SalesN/A27.13432.8198.20
Price / CashN/A19.5636.1658.27
Price / BookN/A6.878.125.65
Net Income-$34.18M-$4.17M$3.25B$257.91M

OncoSec Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$1KN/A0.0040
EFTR
eFFECTOR Therapeutics
0.0726 of 5 stars
$0.00
flat
N/A-99.6%$1KN/A0.0010
PXMD
PaxMedica
N/AN/AN/AN/A$1KN/A0.002
ATNFW
180 Life Sciences
N/A$0.01
-6.3%
N/A-15.6%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.14
+16.8%
N/AN/A$0.00$106.21K0.0040
ALVOW
Alvotech
N/A$1.59
-3.6%
N/A-33.7%$0.00$585.60M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+75.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-11.4%
N/A+99.8%$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.01
+20.0%
N/A-97.3%$0.00$199.38M0.00N/A

Related Companies and Tools


This page (NASDAQ:ONCSQ) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners